- Home
- RCUS vs KRC Comparison
RCUS vs KRC Comparison
Compare RCUS & KRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RCUS | KRC |
|---|---|---|
| Founded | 2015 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.4B |
| IPO Year | 2018 | 1996 |
Fundamental Metrics
Financial Performance| Metric | RCUS | KRC |
|---|---|---|
| Price | $24.23 | $34.50 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 12 |
| Target Price | $31.90 | ★ $37.36 |
| AVG Volume (30 Days) | ★ 1.4M | 1.0M |
| Earning Date | 05-05-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 6.57% |
| EPS Growth | N/A | ★ 31.07 |
| EPS | N/A | ★ N/A |
| Revenue | $247,000,000.00 | ★ $1,112,667,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $45.62 | $2.13 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $11.58 | $27.36 |
| 52 Week High | $31.74 | $45.03 |
Technical Indicators
Market Signals| Indicator | RCUS | KRC |
|---|---|---|
| Relative Strength Index (RSI) | 25.83 | 34.24 |
| Support Level | $23.91 | $33.29 |
| Resistance Level | $24.33 | $35.69 |
| Average True Range (ATR) | 1.31 | 0.78 |
| MACD | -0.71 | -0.13 |
| Stochastic Oscillator | 0.66 | 14.66 |
Price Performance
Historical ComparisonAbout RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.
About KRC Kilroy Realty Corporation
Kilroy Realty is a premier owner and landlord of approximately 16.3 million square feet of office space across Los Angeles, San Diego, the San Francisco Bay Area, Austin, Texas, and greater Seattle. The company operates as a real estate investment trust.